- €95.86m
- €117.23m
- €24.12m
Brief: Pierrel Buys Assets From 3M Company For $70 Mln
Brief: Pierrel FY Net Result Swings To Profit Of EUR 1.4 Mln
Brief: Pierrel 9-Month Net Result Swings To Loss Of EUR 0.4 Mln
Brief: Pierrel H1 Net Result Turns To Net Loss Of EUR 0.4 Mln
Brief: Pierrel Approves Merger By Incorporation Of Unit Pierrel Pharma
Brief: Pierrel Q1 Net Profit Down To EUR 0.5 Mln
Brief: Pierrel FY Net Profit Up To EUR 2.9 Mln
Brief: Pierrel Obtains Marketing Authorization For Orabloc® In Turkmenistan
Brief: Pierrel Launches Orabloc Dental Needles In The United States
Brief: Pierrel Obtains Marketing Authorization Of Orabloc® In Moldova
Brief: Pierrel Acquires Two Products For Saudi Arabia Market
Brief: Pierrel Obtains CE Marking Certification For Ubigel Inperio Medical Device
Brief: Pierrel Obtains Approval For Registration Of Mepivacaine-Based Dental Anaesthetic In Kazakhstan
Brief: Pierrel Obtains Approval To Registration Of Mepivacaine-Based Dental Anesthetic In Taiwan
Brief: Pierrel Obtains Authorization To Commercialise Orabloc In Greece
Brief: Pierrel Receives Authorization To Sell Orabloc In Bosnia-Herzegovina
Brief: Pierrel 9-Month Net Profit Up At EUR 1.4 Mln
Brief: Pierrel Gets Out Of Italy's Market Watchdog "Grey List"
Brief: Pierrel H1 Net Profit Down At EUR 0.7 Mln